Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunotherapy vs immuno-chemotherapy in metastatic kidney carcinoma
2006-003746-42Phase 3Active
- Sponsor
- Oncology Institute of Bari
- Start
- Oct 2006
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in kidney cancer comparing IL-2 immunotherapy alone with IL-2 + gemcitabine + vinorelbine (2 arms). Primary endpoint: Primary efficacy comparison of IL-2 + gemcitabine + vinorelbine versus IL-2 alone. Started Oct 2006; status: active.
02
Drugs
aldesleukingemcitabinevinorelbine
03
Conditions
kidney cancer
Beyond the preview
Go deeper on 2006-003746-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003746-42.